Femalefil 10 mg RSM Enterprises

£36.00

Femalefil 10 mg is a tadalafil citrate pharmaceutical compound developed by RSM Enterprises for female-specific erectile dysfunction research applications in laboratory settings.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Femalefil 10 mg RSM Enterprises
Femalefil 10 mg RSM Enterprises
£36.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Comprehensive Research Profile

Femalefil 10 mg is a tadalafil citrate pharmaceutical compound specifically formulated by RSM Enterprises for in-vitro research investigating female erectile dysfunction mechanisms. This phosphodiesterase-5 inhibitor provides researchers with standardised 10 mg dosage units to examine tissue-selective vascular responses and smooth muscle relaxation pathways. Scientists investigating cardiovascular physiology and sexual health research protocols can source this compound through Stroid UK Shop alongside complementary research compounds.

Laboratory Investigation Applications

Research teams utilise Femalefil to analyse the molecular mechanisms of female sexual arousal disorders and vascular insufficiency conditions. The compound enables examination of nitric oxide-cGMP signalling pathways in genital tissue samples and smooth muscle cell cultures. Comparative studies evaluate tadalafil’s effects against other PDE5 inhibitors available in our erection drugs category for comprehensive pharmaceutical research protocols. Academic laboratories studying cardiovascular medicine can investigate this compound alongside selective androgen receptor modulators and peptide compounds for multi-pathway research approaches.

Technical Specifications

Femalefil 10 mg Research Parameters
Parameter Specification
Active Compound Tadalafil Citrate
Dosage Form 10 mg tablets
Manufacturer RSM Enterprises
CAS Number Verify with supplier
Molecular Formula Verify with supplier
Storage Requirements Room temperature, dry environment
Research Applications Female sexual dysfunction studies

Research Compliance Requirements

This compound is supplied exclusively for legitimate scientific research purposes and in-vitro laboratory investigations. Femalefil 10 mg RSM Enterprises is not approved for human consumption, therapeutic use, or clinical applications. Researchers must maintain appropriate laboratory controls and documentation protocols when investigating this pharmaceutical compound. All studies must comply with institutional research guidelines and applicable laboratory safety regulations.

Related